Alpine Immune Sciences Inc

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing innovative protein-based immunotherapies. Its primary aim is to address serious autoimmune and inflammatory diseases and cancer. It operates with a potentially global reach. Functioning within the biotechnology sector, Alpine Immune Sciences Inc concentrates on engineering novel molecules that modulate immune responses through unique approaches. The company aims to develop therapies offering potential clinical benefits for patients with complex immune-mediated conditions and malignancies. Track the share price of ALPN by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.